Navigation Links
DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects
Date:5/4/2013

Los Angeles, CA (PRWEB) May 04, 2013

The diabetes drug safety advocates at DrugRisk.com are announcing updated information for patients who have taken the medication Byetta. A recent study suggests the drug may have higher occurrence rates of pancreatic cancer and thyroid cancer than traditional treatments.

DrugRisk was created to improve the safety of those taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Patients can see if others are experiencing similar side effects and decide if they need legal advice.

Byetta is a twice-daily injectable medication released in 2005 to help those with type-2 diabetes control blood sugar. It generated sales of over $300 million last year, when it was purchased with Amylin Pharmaceuticals by Bristol-Myers Squibb*.

However, DrugRisk has added a 2011 study from UCLA indicating Byetta could increase the risk of pancreatic cancer by 290% and thyroid cancer by 473%**. The Journal for the American Medical Association also recently published findings showing these drugs can double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

Now, DrugRisk has added a new report by the Institute for Safe Medication Practices, which found in an analysis of FDA reports that patients were over 20 times as likely to report pancreatitis, pancreatic cancer or thyroid cancer from Januvia than from traditional diabetes treatment like metformin****.

Due to the number of patients filing a Byetta lawsuit alleging cancer, lawyers have asked that cases be consolidated to a special federal multi-district court in California****. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Anyone affected by cancer after taking Byetta is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Byetta lawsuits.

For more information on the research, side effects and litigation news related to Byetta and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****Institute for Safe Medication Practices, 4/18/13; ismp.org/QuarterWatch/pdfs/2012Q3.pdf
*****JPML, 4/5/13; cdn.aboutlawsuits.com/wp-content/uploads/2013-04-05-Incretin-Mimetics-MDL.pdf

Read the full story at http://www.prweb.com/releases/byetta-lawsuit/side-effects/prweb10699747.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
2. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
3. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
4. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
5. DrugRisk Announces Launch of Byetta Cancer Resource Center
6. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
7. DrugRisk Announces Addition of Januvia Cancer Resource Center
8. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
9. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
10. DrugRisk Announces Launch of DePuy Hip Resource Center
11. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Western University ... health services to the developmentally disabled in the Coachella Valley. , The two ... new facility at 71-949 Highway 111, Suite 100-B, in Rancho Mirage, California. The ...
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing ... February 2016. Each webinar features a dynamic expert and thoughtful presentation to give ... patients and facilities. Both events are free to attend, but registration is ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... American Academy of Emergency Medicine , an emergency medicine professional association, ... practice management services . , The American Academy of Emergency Medicine, or AAEM, ...
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water ... were three leading bottled water brand owners that topped the list as a result ... and optimize conversion. The premier brand was Tibet 5100, a top notch water company ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Mylan N.V. (NASDAQ, TASE: MYL) today announced ... December 31, 2015. --> --> ... revenues of $9.45 billion, up 28% on a constant ... of $9.43 billion. Excluding the impact of the acquisition ... generics business (the "EPD Business"), full year adjusted total ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, LLC, ... new approaches to the treatment of lupus and ... a multiple ascending dose study in patients with ... RSLV-132. --> --> ... multiple ascending dose study of RSLV-132 in 32 ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: